Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Researchers launch major study to better measure muscle disease progression

NCT ID NCT05989620

First seen Nov 18, 2025 · Last updated May 25, 2026 · Updated 23 times

Summary

This 24-month study follows up to 1000 people with limb girdle muscular dystrophy, myotonic dystrophy type 2, or late-onset Pompe disease. Researchers will test simple physical tasks like walking and timed tests to see which measurements best track disease changes over time. The goal is to develop better tools for future clinical trials, not to provide a treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LGMD2I are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Email: •••••@•••••

Locations

  • Virginia Commonwealth University

    RECRUITING

    Richmond, Virginia, 23298, United States

    Contact Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.